Literature DB >> 15634945

Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.

Margareta M Ieven1, Vicky Y Hoymans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15634945      PMCID： PMC540187          DOI： 10.1128/JCM.43.1.19-24.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  76 in total

1.  Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications.

Authors:  G Ong; B J Thomas; A O Mansfield; B R Davidson; D Taylor-Robinson
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

2.  Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms.

Authors:  F Blasi; F Denti; M Erba; R Cosentini; R Raccanelli; A Rinaldi; L Fagetti; G Esposito; U Ruberti; L Allegra
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

3.  Significance of Chlamydia pneumoniae (TWAR) in atherosclerotic lesions.

Authors:  R W Wissler
Journal:  Circulation       Date:  1995-12-15       Impact factor: 29.690

4.  Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques.

Authors:  M Puolakkainen; C C Kuo; A Shor; S P Wang; J T Grayston; L A Campbell
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

5.  Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery.

Authors:  J T Grayston; C C Kuo; A S Coulson; L A Campbell; R D Lawrence; M J Lee; E D Strandness; S P Wang
Journal:  Circulation       Date:  1995-12-15       Impact factor: 29.690

6.  Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries.

Authors:  C C Kuo; A Shor; L A Campbell; H Fukushi; D L Patton; J T Grayston
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

7.  Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients.

Authors:  C A Gaydos; P M Roblin; M R Hammerschlag; C L Hyman; J J Eiden; J Schachter; T C Quinn
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

8.  Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques.

Authors:  A Shor; C C Kuo; D L Patton
Journal:  S Afr Med J       Date:  1992-09

9.  Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy.

Authors:  S M Weiss; P M Roblin; C A Gaydos; P Cummings; D L Patton; N Schulhoff; J Shani; R Frankel; K Penney; T C Quinn; M R Hammerschlag; J Schachter
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

10.  Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.

Authors:  L A Campbell; E R O'Brien; A L Cappuccio; C C Kuo; S P Wang; D Stewart; D L Patton; P K Cummings; J T Grayston
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226
View more
  19 in total

1.  Impact of seropositivity to Chlamydia pneumoniae and anti-hHSP60 on cardiovascular events in hemodialysis patients.

Authors:  Pasquale Esposito; Carmine Tinelli; Carmelo Libetta; Elisa Gabanti; Teresa Rampino; Antonio Dal Canton
Journal:  Cell Stress Chaperones       Date:  2010-10-05       Impact factor: 3.667

Review 2.  Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?

Authors:  Kensuke Shima; Gregor Kuhlenbäumer; Jan Rupp
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

Review 3.  Antibiotic resistance in Chlamydiae.

Authors:  Kelsi M Sandoz; Daniel D Rockey
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

Review 4.  In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results?

Authors:  Petra Apfalter; Udo Reischl; Margaret R Hammerschlag
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

5.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

6.  Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns.

Authors:  Sebastian Bunk; Hanne Schaffert; Bianca Schmid; Christoph Goletz; Sabine Zeller; Marina Borisova; Florian Kern; Jan Rupp; Corinna Hermann
Journal:  Clin Vaccine Immunol       Date:  2010-03-10

7.  Atherosclerosis, inflammation and Chlamydia pneumoniae.

Authors:  Giovanni Fazio; Maria Giovino; Alessandro Gullotti; Daniela Bacarella; Giuseppina Novo; Salvatore Novo
Journal:  World J Cardiol       Date:  2009-12-31

8.  Host cell cytokines induced by Chlamydia pneumoniae decrease the expression of interstitial collagens and fibronectin in fibroblasts.

Authors:  Jürgen Baumert; Karl-Hermann Schmidt; Annett Eitner; Eberhard Straube; Jürgen Rödel
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

9.  A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases.

Authors:  Zhi Song; Paul Brassard; James M Brophy
Journal:  Can J Cardiol       Date:  2008-05       Impact factor: 5.223

10.  Assessment of some inflammatory biomarkers as predictors of outcome of acute respiratory failure on top of chronic obstructive pulmonary disease and evaluation of the role of bacteria.

Authors:  Hanaa Ahmed Shafiek; Nashwa Hassan Abd-Elwahab; Manal Mohammad Baddour; Mohamed Mabrouk El-Hoffy; Akram Abd-Elmoneim Degady; Yehia Mohamed Khalil
Journal:  ISRN Microbiol       Date:  2012-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.